Dimethyllysergamide
Dimethyllysergamide[edit | edit source]
Dimethyllysergamide (also known as DAM-57) is a chemical compound belonging to the ergoline family. It is a derivative of lysergic acid and is structurally related to lysergic acid diethylamide (LSD). Dimethyllysergamide is of interest in the field of psychopharmacology due to its potential psychoactive properties.
Chemical Structure and Properties[edit | edit source]
Dimethyllysergamide is characterized by its ergoline backbone, which is a tetracyclic structure. The compound is a lysergamide, meaning it is an amide of lysergic acid. The chemical structure of Dimethyllysergamide includes two methyl groups attached to the nitrogen atom of the amide group, distinguishing it from other lysergamides such as LSD, which has ethyl groups instead.
Pharmacology[edit | edit source]
The pharmacological effects of Dimethyllysergamide are not as well-studied as those of LSD. However, it is believed to interact with the serotonin receptors in the brain, similar to other compounds in the ergoline family. This interaction is thought to be responsible for its potential psychoactive effects.
Synthesis[edit | edit source]
The synthesis of Dimethyllysergamide involves the chemical modification of lysergic acid. The process typically includes the formation of the amide bond between lysergic acid and dimethylamine. This synthesis requires careful control of reaction conditions to ensure the correct formation of the desired product.
Potential Uses and Research[edit | edit source]
Research into Dimethyllysergamide is limited, but it is of interest for its potential use in psychedelic therapy and as a tool for understanding the neurobiology of consciousness. Studies on similar compounds have shown promise in treating conditions such as depression and post-traumatic stress disorder (PTSD).
Legal Status[edit | edit source]
The legal status of Dimethyllysergamide varies by country. In many places, it is not specifically scheduled, but it may be considered an analogue of LSD and thus subject to similar legal restrictions under analogue laws.
Related Pages[edit | edit source]
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD
